News in brief...

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Subject Terms:
      UNITED States. Food & Drug Administration
    • Abstract:
      Presents news briefs on the pharmaceutical industry as of August 27, 2005. Revisions made to the labeling of US Relafen; Ayurvedic medicines available on the British market that may contain high heavy metal levels, according to the UK Medicines and Healthcare products Regulatory Agency; Rejection by the U.S. Food and Drug Administration to the petition submitted by the U.S. consumer group Public Citizen to ban Meridia.